Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardian Pharmacy Services (GRDN) Invested Capital (2023 - 2025)

Guardian Pharmacy Services' Invested Capital history spans 3 years, with the latest figure at $217.9 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 45.31% year-over-year to $217.9 million; the TTM value through Dec 2025 reached $217.9 million, up 45.31%, while the annual FY2025 figure was $217.9 million, 45.31% up from the prior year.
  • Invested Capital for Q4 2025 was $217.9 million at Guardian Pharmacy Services, up from $195.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $217.9 million in Q4 2025 and bottomed at $56.6 million in Q1 2024.
  • The 3-year median for Invested Capital is $150.0 million (2024), against an average of $137.0 million.
  • The largest YoY upside for Invested Capital was 214.04% in 2025 against a maximum downside of 35.86% in 2025.
  • A 3-year view of Invested Capital shows it stood at $68.9 million in 2023, then soared by 117.8% to $150.0 million in 2024, then skyrocketed by 45.31% to $217.9 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Invested Capital are $217.9 million (Q4 2025), $195.5 million (Q3 2025), and $179.7 million (Q2 2025).